SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-21-078253
Filing Date
2021-06-08
Accepted
2021-06-08 16:25:31
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2119092-1_424b5.htm 424B5 601243
2 GRAPHIC lg_aclaristherapeutic-4c.jpg GRAPHIC 39949
  Complete submission text file 0001104659-21-078253.txt   657392
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-256337 | Film No.: 211002432
SIC: 2834 Pharmaceutical Preparations